Next Article in Journal
Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms
Next Article in Special Issue
Emerging Concern with Imminent Therapeutic Strategies for Treating Resistance in Biofilm
Previous Article in Journal
Surgical Antimicrobial Prophylaxis in Abdominal Surgery for Neonates and Paediatrics: A RAND/UCLA Appropriateness Method Consensus Study
Previous Article in Special Issue
Novel Plant-Based Metabolites as Disinfectants against Acanthamoeba castellanii
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Statins Induce Actin Cytoskeleton Disassembly and an Apoptosis-Like Process in Acanthamoeba spp.

by
Rubén L. Rodríguez-Expósito
1,2,3,
Ines Sifaoui
1,2,3,
María Reyes-Batlle
1,2,3,
Sutherland K. Maciver
4,
José E. Piñero
1,2,3,5,* and
Jacob Lorenzo-Morales
1,2,3,5,*
1
Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de la Laguna (ULL), 38206 Tenerife, Spain
2
Departamento de Obstetricia, Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de la Laguna (ULL), La Laguna, Tenerife, 38203 Islas Canarias, Spain
3
Red de Investigación Cooperativa en Enfermedades Tropicales (RICET), 28029 Madrid, Spain
4
Centre for Integrative Physiology, Biomedical Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh EH8 9AG, UK
5
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain
*
Authors to whom correspondence should be addressed.
Antibiotics 2022, 11(2), 280; https://doi.org/10.3390/antibiotics11020280
Submission received: 20 January 2022 / Revised: 7 February 2022 / Accepted: 17 February 2022 / Published: 21 February 2022
(This article belongs to the Special Issue New Insights in Antimicrobial Discovery)

Abstract

:
Acanthamoeba is a ubiquitous opportunistic protozoan pathogen that is known to cause blinding keratitis and rare, but usually fatal, granulomatous encephalitis. The difficulty in treating infections and the toxicity issues of the current treatments emphasize the need to use alternative agents with amoebicidal activity. The aim of this study was to evaluate the in vitro antiamoebic activity of three third-generation statins—cerivastatin, pitavastatin and rosuvastatin—against both cysts and trophozoites of the following four strains of Acanthamoeba: A. castellanii Neff, A. polyphaga, A. griffini and A. quina. Furthermore, programmed cell death (PCD) induction traits were evaluated by measuring chromatin condensation, damages at the mitochondrial level, production of reactive oxygen species (ROS) and the distribution of actin cytoskeleton fibers. Acanthamoeba castellanii Neff was the strain most sensitive to all the statins, where cerivastatin showed the lowest amoebicidal activity for both trophozoite and cyst forms (0.114 ± 0.050 and 0.704 ± 0.129 µM, respectively). All the statins were able to cause DNA condensation, collapse in the mitochondrial membrane potential and a reduction in ATP level production, and disorganization of the total actin fibers in the cytoskeleton of all the evaluated Acanthamoeba strains. Our results showed that the tested statins were able to induce PCD compatible events in the treated amoebae, including chromatin condensation, collapse in the mitochondrial potential and ATP levels, cytoskeleton disassembly and ROS generation.

1. Introduction

Acanthamoeba is a genus of pathogenic, free-living amoebae that can cause several opportunistic infections in humans, namely, Acanthamoeba keratitis (AK), granulomatous amoebic encephalitis (GAE) and disseminated infections (mostly cutaneous and nasopharyngeal) [1]. Based on rRNA gene sequence analyses, 23 different genotypes have been reported to date (T1 to T23), with T4 being the most abundant genotype in both clinical and environmental samples. Acanthamoeba are mixotrophic and can encyst under unfavorable conditions [2,3]. Currently, the treatment of Acanthamoeba infections remains an issue, due to the presence of cyst forms and to the variability in drug efficacy among different genotypes, in addition to the long periods of drug administration and drug toxicity. Hence, there is an urgent need to validate new amoebicidal molecules that target essential biosynthesis pathways in Acanthamoeba. Ergosterol and 7-dehyrostigmasterol have been reported as the major sterols on the membrane of Acanthamoeba, for both cyst and trophozoite stages [4]. Being vital to Acanthamoeba, the ergosterol biosynthesis pathway could be used as a potential drug target [5,6]. The 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA) enzyme catalyzes the synthesis of ergosterol in fungi, plant, and free-living amoeba; consequently, inhibiting or blocking this enzyme should induce irreversible damage in the amoebic membrane [5].
Statins are cholesterol-lowering drugs that are primarily used for hypercholesterolemia therapy [7]. These molecules act as competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase [1]. Three generations of statins were developed, based on their efficacy to lower the plasma low-density lipoprotein cholesterol (LDL-C) concentration. The first-generation statins include lovastatin, pravastatin and fluvastatin, while the second generation includes atorvastatin, and rosuvastatin, pitavastatin and cerivastatin constitute the third-generation statins [8].
In previous studies, we have already confirmed the amoebicidal activity of many statins, namely, fluvastatin and pravastatin, which are first-generation statins, and atorvastatin and simvastatin, which are second-generation statins [5]. Martin-Navarro et al. (2015) have confirmed that statins can induce irreversible cell membrane damage, as well as apoptotic-like features in A. castellanii Neff, including chromatin condensation [1]. In addition, Hahn et al. (2020) have recently reported that the amoebicidal activity of pitavastatin against A. castellanii Neff was 10 times higher than that of rosuvastatin [9]. In the present work, the amoebicidal activity of three different third-generation statins against the cyst and trophozoite stages of four Acanthamoeba strains was evaluated. In addition, their effect on actin distribution and the induction of different apoptosis-like features were studied, including chromatin condensation and mitochondrial damage.

2. Results

2.1. In Vitro Activity of Statin against Acanthamoeba spp.

In the present study, three different third-generation statins were evaluated to identify their activities against four Acanthamoeba strains. All the IC50 values are summarized in Table 1. The ANOVA analysis revealed that both trophocidal and cysticidal activities were significantly dependent on the strain and statin used, with p < 0.0001.
Indeed, for both cysticidal and trophocidal activities, Acanthamoeba castellanii Neff was the most sensitive strain, while Acanthamoeba polyphaga was the most resistant. As for the type of statin used, rosuvastatin was less active against both cyst and trophozoite forms of all the tested strains. As for cerivastatin and pitavastatin, their amoebicidal activity was not statistically significant, except for the cyst stage of Acanthamoeba polyphaga, where cerivastatin was more active than pitavastatin.

2.2. Statins Induced Actin Cytoskeleton Disassembly

Actin networks and the organization of cytoskeletal structures are indispensable elements of the cellular morphology, adhesion, motility and pathogenicity of adherent cells, namely, Acanthamoeba [10]. Thus, we inspected the eventual effect of statins on the cytoskeleton and the actin’s network, using specific actin staining. After 24 h of incubation with the statins at IC90, (Table 2) the rounded cells emitted less intense fluorescence than the negative control (Figure 1A,F,K,P), reflecting complete disorganization of the actin fibers and total loss of the cytoskeletal structure (Figure 1).

2.3. Statin Treatments Induce Compatible Events Related to Programmed Cell Death of Amoebae

The lipid-lowering drugs, statins, were reported to induce apoptosis in a variety of tumor cells [11], as well as free-living amoeba, such as Acanthamoeba [1], Naegleria fowleri [12] and Trypanosoma [13] among others. From Figure 2, we can distinguish the following three groups: non-stained cells as healthy cells; cells undergoing an early apoptosis process, with bright blue stained nuclei; cells in a late apoptotic process, stained blue and red.

2.4. Statins Decreased ATP Levels during the Time of Incubation

We further evaluated the effect of the statins on the total ATP levels produced in the treated cells, relative to the control. We found that all the statins could reduce ATP production by at least 50%. The reductions were affected by both the type of strain and molecules used. For Acanthamoeba quina, the ATP produced by the different statins was statistically significant, with a higher decrease induced by cerivastatin. However, in Acanthamoeba castellanii Neff, the difference between the three molecules was non to slightly significant (Figure 3).

2.4.1. Statins Induced the Collapse of Mitochondrial Membrane Potential (ΔΨm)

The mitochondrial membrane potential, (ΔψM), is an indispensable element for good mitochondrial function. JC-1 is a permeable, lipophilic, cationic dye that can selectively stain mitochondria and reversibly change color from its green monomer form to red, as the membrane potential increases, for its dimeric form. Figure 4 shows the JC-1 dye emitting green fluorescence, showing that all the statins can induce depolarization of the mitochondrial potential. Indeed, JC-1 remained in the cytoplasm in its monomeric form. In healthy cells, the high mitochondria membrane potential allows the dye to accumulate and aggregate in the mitochondria and emit a red fluorescence signal (Figure 4A,E,I,M).

2.4.2. Statins Increase Reactive Oxygen Species (ROS) Levels in Acanthamoeba

In order to evaluate the effect of the statins on the cell’s oxidative state, staining, using CellROX Deep RedTM, was conducted. Figure 5 shows that the treatment of Acanthamoeba spp. with different statins noticeably enhanced the red fluorescence, particularly in Acanthamoeba castellanii Neff, reflecting the increase in ROS intracellular production.

3. Discussion

Statins are widely used in hypercholesterolemia treatment, due to their great inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase [14]. This enzyme catalyzes the reduction of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonate, which is considered a mandatory step in cholesterol and ergosterol biosynthesis [15]. In addition, several reports have recently shown that statins can affect cytoskeleton distribution, resulting in a loss of cell surface, motility and adhesion. Kuipers et al. (2006) have reported that simvastatin can affect the shape and adhesive capacity of microglia cells by altering their actin network [14]. In our previous work, we identified the gene encoding for Acanthamoeba HMG-CoA reductase, and we reported the use of statins as amoebicidal drugs via the inhibition of the last enzyme. Ergosterol and 7-dehyrostigmasterol constitute the main sterols of Acanthamoeba’s membrane. Therefore, blocking their synthesis normally led to the membrane architecture of Acanthamoeba becoming defective [1,5].
Among the three tested statins, the amoebicidal activity of pitavastatin and rosuvastatin has been reported in A. castellanii. The authors found that pitavastatin was more active than rosuvastatin, and it could inhibit the following different Acanthamoeba strains: CDC:V240 and MEEI 0184 [9]. In concordance, in the present work, cerivastatin and pitavastatin were more active than rosuvastatin against both stages of the four Acanthamoeba strains tested.
Phalloidin staining was processed to visualize the effect of the statins on Acanthamoeba’s actin network. Phalloidin is a fungal toxin that specifically binds to F-actin, resulting in the stabilization of actin filaments. We could visualize that the cells treated with statins emitted lower fluorescence than the negative control, demonstrating that the present drugs can induce actin stress fiber distribution. Phalloidin staining in the negative control revealed the presence of regular actin filaments and a highly organized dense network. In contrast, most of the treated cells lost their membrane architecture and showed the presence of cytoskeleton disorganization. The effect of the statins on the actin cytoskeletons was similar to that elicited by methyl-β-cyclodextrin treatment, which is known to sequester membrane sterols, supporting the contention that statins act on actin cytoskeletons by lowering sterols. Effectively, statins could affect the cytoskeleton of Acanthamoeba spp., and this would result in rounded cells, without a defined shape. Similar morphological features were observed in a cardiac fibroblast by Copaja et al. (2012). The authors reported that cells treated with simvastatin presented smaller sizes, rounder shapes and complete disruptions to their actin networks [16]. In another report, Sokalska et al. (2010) proposed a mechanism of action of simvastatin on the cytoskeleton of endometrial stromal cells via the reduction of geranylgeranyl diphosphate and, hence, the decrease in protein geranylgeranylation, namely, in Rho, Rac, and Cdc42. In fact, those proteins regulate the organization of actin cytoskeletons, and could constitute a good target to inhibit Acanthamoeba cells by preventing their adhesion and damaging their cytoskeleton [17].
In addition to their clinical use to lower serum cholesterol levels, statins have been reported to induce apoptosis in several experimental models, namely, tumors, such as C6 glioma cells, acute myeloid leukemia and human lymphocytes. Tsubaki et al. (2015) reported that simvastatin and fluvastatin can inhibit metastatic mouse melanoma growth via the abolition of cell motility and cycle progress keys, such as metalloproteinases (MMPs), very late antigens (VLAs) and Rho prenylation [18]. As for pitavastatin, it was described to induce apoptosis in oral cancer cells via the activation of caspase 3/9 [19].
Regarding protists, it has been demonstrated that atorvastatin, and other drugs that interfere with the sterol biosynthetic pathway, induce PCD in trypanosomatids [13]. In Acanthamoeba, we demonstrated, in previous work, that atorvastatin, fluvastatin, simvastatin and voriconazole induce cellular DNA fragmentation and chromatin condensation [1]. Furthermore, 24 h of incubation with those statins induces apoptosis in Acanthamoeba castellanii Neff via caspase 3. In the present work, the three tested statins could induce oxidative stress in Acanthamoeba spp. by increasing the production of ROS. Further experiments evaluating the effect of ROS accumulation on proapoptotic markers would be interesting.

4. Materials and Methods

4.1. Chemicals

In the present study, three different statins were evaluated for their amoebicidal activity, namely, cerivastatin, rosuvastatin and pitavastatin. All molecules were purchased from Cayman Chemicals (Vitro SA, Madrid, Spain). As a positive control, chlorhexidine was used. Stock solutions were prepared in dimethyl sulfoxide (DMSO) and maintained at −20 °C until required. In the whole experiment, a maximum of 0.1% of DMSO was used.

4.2. Acanthamoeba Strains

An amoebicidal effect was observed against the following four strains of Acanthamoeba: Acanthamoeba castellanii Neff, genotype T4 (ATCC 30010) strain from the American Type Culture Collection; Acanthamoeba griffini, genotype T3 obtained in previous studies (14); Acanthamoeba polyphaga, genotype T4 (ATCC 30461); Acanthamoeba quina, genotype T4 (ATCC 50241). Those strains were grown axenically at 26 °C for 3 days in PYG medium (0.75% (w/v) proteose peptone, 0.75% (w/v) yeast extract and 1.5% (w/v) glucose), containing 40 μg gentamicin mL−1 (Biochrom AG, Cultek, Granollers, Barcelona, Spain), before being used.

4.3. In Vitro Effect against the Trophozoite Stage of Acanthamoeba

The anti-Acanthamoeba activity of the tested molecules was determined by alamarBlue® Reagent assay, as previously described [20]. Briefly, Acanthamoeba strains were seeded in triplicate on a 96-well microtiter plate with 50 μL from a stock solution of 5 × 104 cells/mL. Amoebae were allowed to adhere for 15 min and 50 μL of serial dilution series of the drug was added. Finally, the alamarBlue® Reagent was added into each well at an amount equal to 10% of the medium volume (Life Technologies, Madrid, Spain). The plates were then incubated for 96 h at 26 °C with slight agitation and the emitted fluorescence was measured with an EnSpire® Multimode Plate Reader (Perkin Elmer, Madrid, Spain) at 570/585 nm.

4.4. In Vitro Effect against the Cyst Stage of Acanthamoeba spp.

Preparation of mature cysts.
Briefly, trophozoites were transferred from PYG medium-based cultures (trophozoite medium) to Neff’s encystment medium (NEM; 0.1 M KCl, 8 mM MgSO4·7H2O, 0.4 mM CaCl2·2H2O, 1 mM NaHCO3, 20 mM ammediol [2-amino-2-methyl-1,3-propanediol; Sigma Aldrich Chemistry Ltd., Madrid, Spain], pH 8.8, at 25 °C) and were cultured in this medium with gentle shaking for two weeks in order to obtain mature cysts. After that, mature cysts were harvested and washed twice using PYG medium [21].
The cysticidal activity was determined by the alamarBlue® method at 144 h and confirmed visually by inverted microscopy. The in vitro susceptibility assay was performed in sterile 96-well microtiter plates (Corning™, New York, NY, USA). First, a serial dilution of the tested molecules was made in PYG. Then, 50 µL of mature cysts at a concentration of 5 × 104/mL were added to all the wells. The plates were examined with inverted microscopy, and after 7 days of incubation, the plates were centrifuged at 800× g for 10 min and the medium was replaced with new PYG. Finally, 10 μL of the alamarBlue® Reagent (Biosource, Europe, Nivelles, Belgium) was placed into each well, and the plates were then incubated for 144 h at 26 °C with slight agitation, and the emitted fluorescence was examined with an EnSpire® Multimode Plate Reader (Perkin Elmer, Madrid, Spain) at 570/585 nm.

4.5. Fluorescent Staining of Actin Distribution

For direct fluorescent staining, samples were treated first with the IC90 of the statin. After 24 h of incubation, cells were fixed with formaldehyde and deposited on a pre-coated coverslip. Later, cells were treated with Triton (0.1%) for 30 min followed by phalloidin-tetramethylrhodamine B isothiocyanate (phalloidin-TRITC; Sigma-Aldrich, Madrid, Spain) for another 30 min at room temperature. Finally, cells were washed with PBS. Cells were examined by Z-stack imaging with a 100× objective of EVOS FL Cell Imaging System AMF4300, Life Technologies, Carlsbad, CA, USA, at λexc = 540 nm and λem = 570 nm. As a positive control of actin depolymerization, methyl-β-cyclodextrin (BioReagent, Sigma-Aldrich, Madrid, Spain) was used [22]. Non-treated cells, containing 0.1% of DMSO, were considered as the negative control.

4.6. Evaluation of Programmed Cell Death (PDC) Induction

In all the fluorescence microscopy assays, the images were captured using an EVOS FL Cell Imaging System EVOS™ M5000 (100× magnification). In addition, the images shown are representative of the cell populations observed in each experimental condition. All the experiments were performed in triplicate.

4.7. Double-Stain Assay for Programmed Cell Death Determination

A double-stain apoptosis detection kit, Chromatin Condensation/Dead Cell Apoptosis Kit with Hoechst 33,342 and PI (Invitrogen, Madrid, Spain), and an EVOS FL Cell Imaging System EVOS™ M5000 (Life Technologies, Madrid, Spain), were used. The experiment was carried out by following the manufacturer’s recommendations, and 2 × 105 cells/well were incubated for 24 h with the previously calculated IC90. The double-staining pattern allows for the identification of three groups in a cellular population; live cells show only a low level of fluorescence, cells undergoing PCD show a higher level of blue fluorescence (as chromatin condenses), and dead cells show low blue and high red fluorescence (as the propidium iodide stain enters the nucleus) [23].

4.8. Measurement of ATP

ATP levels produced over time were measured using a CellTiter-Glo® Luminescent Cell Viability Assay (Promega, Madrid, Spain). The effect of the drug on the ATP inhibition was evaluated by incubating 2 × 105 of cells/mL with the previously calculated IC90 of the present solution [23].

4.9. Intracellular ROS Production Using CellROX® Deep Red Staining

The generation of intracellular ROS was detected using the CellROX® Deep Red fluorescent probe (Invitrogen, Madrid, Spain). The cells were treated with the IC90 for 24 h and exposed to CellROX® Deep Red (5 μM, 30 min) at 26 °C in the dark. Cells were observed with an EVOS FL Cell Imaging System EVOS™ M5000, Life Technologies, USA [24].

4.10. Analysis of Mitochondrial Membrane Potential

The collapse of an electrochemical gradient across the mitochondrial membrane over time was detected with the JC-1 Mitochondrial Membrane Potential Assay Kit (Cayman, Madrid, Spain). After being treated with IC90 of statins for 24 h, the cells were centrifuged (800× g 10 min) and re-suspended in JC-1 buffer. After that, 50 µL of each treated culture was incubated with 5 µL of JC-1 at 26 °C for 30 min. Images were taken on an EVOS FL Cell Imaging System EVOS™ M5000, Life Technologies, USA. The staining pattern allows the identification of two groups in a cellular population; live cells show only red fluorescence, while cells with low mitochondrial potential (undergoing PCD) show a higher level of green and red fluorescence [24].

4.11. Statistical Analysis

All data are expressed as the mean ± standard deviation of at least three independent experiments. To highlight the effect of both statin and strain, a statistical comparison was conducted using two-way analysis of variance (ANOVA). All the analyses and the graphics were performed by GraphPad Prism version 9.0. Statistical significance was set at p < 0.05.

Author Contributions

Conceptualization, S.K.M.; J.E.P. and J.L.-M.; methodology, R.L.R.-E.; I.S. and M.R.-B.; software, R.L.R.-E. and I.S.; validation, S.K.M.; J.E.P. and J.L.-M.; formal analysis, S.K.M.; J.E.P. and J.L.-M.; investigation, R.L.R.-E.; I.S. and M.R.-B.; resources, J.E.P. and J.L.-M.; data curation, R.L.R.-E.; I.S. and M.R.-B.; writing—original draft preparation, R.L.R.-E.; I.S. and M.R.-B.; writing—review and editing, S.K.M.; J.E.P. and J.L.-M.; visualization, S.K.M.; J.E.P. and J.L.-M.; supervision, J.E.P. and J.L.-M.; project administration, J.E.P. and J.L.-M.; funding acquisition, J.E.P. and J.L.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the RICET (project no. RD16/0027/0001 of the programme of Redes Temáticas de Investigación Cooperativa, FIS), CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (CB21/13/00100), Ministerio de Sanidad, Consumo y Bienestar Social, Spain and Cabildo de Tenerife 21/0587 cofunded by FDCAN and MEDI (Tenerife Innova Programme). RLRE was funded by a grant from Agencia Canaria de Investigación, Innovación y Sociedad de la Información (ACIISI) cofunded by Fondo Social Europeo (FSE) y FEDER, (TESIS2020010117).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Martin-Navarro, C.M.; Lopez-Arencibia, A.; Sifaoui, I.; Reyes-Batlle, M.; Valladares, B.; Martinez-Carretero, E.; Pinero, J.E.; Maciver, S.K.; Lorenzo-Morales, J. Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii. Antimicrob. Agents Chemother. 2015, 59, 2817–2824. [Google Scholar] [CrossRef] [Green Version]
  2. Thomson, S.; Rice, C.A.; Zhang, T.; Edrada-Ebel, R.; Henriquez, F.L.; Roberts, C.W. Characterisation of sterol biosynthesis and validation of 14alpha-demethylase as a drug target in Acanthamoeba. Sci. Rep. 2017, 7, 8247-z. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Putaporntip, C.; Kuamsab, N.; Nuprasert, W.; Rojrung, R.; Pattanawong, U.; Tia, T.; Yanmanee, S.; Jongwutiwes, S. Analysis of Acanthamoeba genotypes from public freshwater sources in Thailand reveals a new genotype, T23 Acanthamoeba bangkokensis sp. nov. Sci. Rep. 2021, 11, 17290. [Google Scholar] [CrossRef] [PubMed]
  4. Smith, F.R.; Korn, E.D. 7-Dehydrostigmasterol and ergosterol: The major sterols of an amoeba. J. Lipid Res. 1968, 9, 405–408. [Google Scholar] [CrossRef]
  5. Martin-Navarro, C.M.; Lorenzo-Morales, J.; Machin, R.P.; Lopez-Arencibia, A.; Garcia-Castellano, J.M.; De Fuentes, I.; Loftus, B.; Maciver, S.K.; Valladares, B.; Pinero, J.E. Inhibition of 3-Hydroxy-3-Methylglutaryl–Coenzyme A Reductase and Application of Statins as a Novel Effective Therapeutic Approach against Acanthamoeba Infections. Antimicrob. Agents Chemother. 2013, 57, 375–381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Dudley, R.; Alsam, S.; Khan, N. Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis. Appl. Microbiol. Biotechnol. 2007, 75, 133–140. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, Y.; Ren, F.; Song, Z.; Chen, P.; Liu, S.; Ouyang, L. Statin use and the risk of ovarian and endometrial cancers: A meta-analysis. BMC Cancer 2019, 19, 730. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Maji, D.; Shaikh, S.; Solanki, D.; Gaurav, K. Safety of statins. Indian J. Endocrinol. Metab. 2013, 17, 636–646. [Google Scholar] [CrossRef]
  9. Hahn, H.J.; Abagyan, R.; Podust, L.M.; Roy, S.; Ali, I.K.M.; Debnath, A. HMG-CoA Reductase Inhibitors as Drug Leads against Naegleria fowleri. ACS Chem. Neurosci. 2020, 11, 3089–3096. [Google Scholar] [CrossRef]
  10. Pozo, M.; de Nicolas, R.; Egido, J.; Gonzalez-Cabrero, J. Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells. Eur. J. Pharmacol. 2006, 548, 53–63. [Google Scholar] [CrossRef]
  11. Koyuturk, M.; Ersoz, M.; Altiok, N. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase. Neurosci. Lett. 2004, 370, 212–217. [Google Scholar] [CrossRef]
  12. Rizo-Liendo, A.; Sifaoui, I.; Arberas-Jimenez, I.; Reyes-Batlle, M.; Pinero, J.E.; Lorenzo-Morales, J. Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri. Biomed. Pharmacother. 2020, 130, 110583. [Google Scholar] [CrossRef]
  13. de Souza, W.; Rodrigues, J.C. Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs. Interdiscip. Perspect. Infect. Dis. 2009, 2009, 642502. [Google Scholar] [CrossRef] [Green Version]
  14. Kuipers, H.F.; Rappert, A.A.; Mommaas, A.M.; van Haastert, E.S.; van der Valk, P.; Boddeke, H.W.; Biber, K.P.; van den Elsen, P.J. Simvastatin affects cell motility and actin cytoskeleton distribution of microglia. Glia 2006, 53, 115–123. [Google Scholar] [CrossRef]
  15. Chappell, J.; Wolf, F.; Proulx, J.; Cuellar, R.; Saunders, C. Is the Reaction Catalyzed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase a Rate-Limiting Step for Isoprenoid Biosynthesis in Plants? Plant Physiol. 1995, 109, 1337–1343. [Google Scholar] [CrossRef] [Green Version]
  16. Copaja, M.; Venegas, D.; Aranguiz, P.; Canales, J.; Vivar, R.; Avalos, Y.; Garcia, L.; Chiong, M.; Olmedo, I.; Catalan, M.; et al. Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration and viability. Toxicology 2012, 294, 42–49. [Google Scholar] [CrossRef]
  17. Sokalska, A.; Piotrowski, P.C.; Rzepczynska, I.J.; Cress, A.; Duleba, A.J. Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability. J. Clin. Endocrinol. Metab. 2010, 95, 5390–5394. [Google Scholar] [CrossRef] [Green Version]
  18. Tsubaki, M.; Takeda, T.; Kino, T.; Obata, N.; Itoh, T.; Imano, M.; Mashimo, K.; Fujiwara, D.; Sakaguchi, K.; Satou, T.; et al. Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model. Am. J. Cancer Res. 2015, 5, 3186–3197. [Google Scholar]
  19. Lee, N.; Tilija Pun, N.; Jang, W.J.; Bae, J.W.; Jeong, C.H. Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a. J. Cell Mol. Med. 2020, 24, 7055–7066. [Google Scholar] [CrossRef]
  20. Martin-Navarro, C.M.; Lorenzo-Morales, J.; Cabrera-Serra, M.G.; Rancel, F.; Coronado-Alvarez, N.M.; Pinero, J.E.; Valladares, B. The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. J. Med. Microbiol. 2008, 57, 1399–1404. [Google Scholar] [CrossRef]
  21. Lorenzo-Morales, J.; Kliescikova, J.; Martinez-Carretero, E.; De Pablos, L.M.; Profotova, B.; Nohynkova, E.; Osuna, A.; Valladares, B. Glycogen phosphorylase in Acanthamoeba spp.: Determining the role of the enzyme during the encystment process using RNA interference. Eukaryot. Cell 2008, 7, 509–517. [Google Scholar] [CrossRef] [Green Version]
  22. Zidovetzki, R.; Levitan, I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochim. Biophys Acta 2007, 1768, 1311–1324. [Google Scholar] [CrossRef] [Green Version]
  23. Sifaoui, I.; Reyes-Batlle, M.; Lopez-Arencibia, A.; Chiboub, O.; Rodriguez-Martin, J.; Rocha-Cabrera, P.; Valladares, B.; Pinero, J.E.; Lorenzo-Morales, J. Toxic effects of selected proprietary dry eye drops on Acanthamoeba. Sci. Rep. 2018, 8, 8520. [Google Scholar] [CrossRef]
  24. Rodriguez-Exposito, R.L.; Nocchi, N.; Reyes-Batlle, M.; Sifaoui, I.; Suarez-Gomez, B.; Diaz-Marrero, A.R.; Souto, M.L.; Pinero, J.E.; Fernandez, J.J.; Lorenzo-Morales, J. Antiamoebic effects of sesquiterpene lactones isolated from the zoanthid Palythoa aff. clavata. Bioorg. Chem. 2021, 108, 104682. [Google Scholar] [CrossRef]
Figure 1. Trophozoites of Acanthamoeba castellanii Neff (AE), A. polyphaga (FJ), A. griffini (KO) and A. quina (PT) incubated with the IC90 of cerivastatin (B,G,L,Q), pitavastatin (C,H,M,R) and rosuvastatin (D,I,N,S) for 24 h. The positive control was processed by treating amoebae with methyl-β-cyclodextrin (E,J,O,T). The phalloidin-TRITC dye stained the actin cytoskeleton, showing a disorganization effect in the positive control and in the amoebae treated with statins, and emitted a lower orange fluorescence than the non-treated cells (negative control: A,F,K,P). All images were captured using the EVOS FL Cell Imaging System EVOS™ M5000 (100× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Figure 1. Trophozoites of Acanthamoeba castellanii Neff (AE), A. polyphaga (FJ), A. griffini (KO) and A. quina (PT) incubated with the IC90 of cerivastatin (B,G,L,Q), pitavastatin (C,H,M,R) and rosuvastatin (D,I,N,S) for 24 h. The positive control was processed by treating amoebae with methyl-β-cyclodextrin (E,J,O,T). The phalloidin-TRITC dye stained the actin cytoskeleton, showing a disorganization effect in the positive control and in the amoebae treated with statins, and emitted a lower orange fluorescence than the non-treated cells (negative control: A,F,K,P). All images were captured using the EVOS FL Cell Imaging System EVOS™ M5000 (100× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Antibiotics 11 00280 g001
Figure 2. Images of Acanthamoeba castellanii Neff (AD), A. polyphaga (EH), A. griffini (IL) and A. quina (MP) showing the effect of IC90 of cerivastatin (B,F,J,N), pitavastatin (C,G,K,O) and rosuvastatin (D,H,L,P), relative to the negative control (non-treated amoebae) (A,E,I,M), after 24 h of incubation in vitro. Hoechst stains treated trophozoites nuclei in bright blue, showing chromatin condensation, while red fluorescence corresponds to the propidium iodide dye, which stains the DNA of dead cells. All images were captured using an EVOS FL Cell Imaging System EVOS™ M5000 (40× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Figure 2. Images of Acanthamoeba castellanii Neff (AD), A. polyphaga (EH), A. griffini (IL) and A. quina (MP) showing the effect of IC90 of cerivastatin (B,F,J,N), pitavastatin (C,G,K,O) and rosuvastatin (D,H,L,P), relative to the negative control (non-treated amoebae) (A,E,I,M), after 24 h of incubation in vitro. Hoechst stains treated trophozoites nuclei in bright blue, showing chromatin condensation, while red fluorescence corresponds to the propidium iodide dye, which stains the DNA of dead cells. All images were captured using an EVOS FL Cell Imaging System EVOS™ M5000 (40× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Antibiotics 11 00280 g002
Figure 3. Effect of IC90 of statins on the ATP production of Acanthamoeba castellanii Neff, A. polyphaga, A. griffini and A. quina trophozoites, using CellTiter-Glo® luminescent cell viability assay. Results are represented as percentages relative to the negative control. Differences between the values were assessed using one-way analysis of variance (ANOVA). Data are presented as means ± SD (N = 3); ns, non-significant. * p < 0.05 and **** p < 0.0001 are significance differences when comparing the different mean values.
Figure 3. Effect of IC90 of statins on the ATP production of Acanthamoeba castellanii Neff, A. polyphaga, A. griffini and A. quina trophozoites, using CellTiter-Glo® luminescent cell viability assay. Results are represented as percentages relative to the negative control. Differences between the values were assessed using one-way analysis of variance (ANOVA). Data are presented as means ± SD (N = 3); ns, non-significant. * p < 0.05 and **** p < 0.0001 are significance differences when comparing the different mean values.
Antibiotics 11 00280 g003
Figure 4. JC-1 dye showing the effect of IC90 of cerivastatin (B,F,J,N), pitavastatin (C,G,K,O) and rosuvastatin (D,H,L,P) in trophozoites of Acanthamoeba castellanii Neff (AD), A. polyphaga (EH), A. griffini (IL) and A. quina (MP) for 24 h of incubation. JC-1 dye remained in its monomeric form inside the treated cells, emitting green fluorescence, suggesting that the statins could induce depolarization of the mitochondrial potential. In healthy trophozoites, JC-1 dye accumulated in aggregates inside the mitochondria, emitting red fluorescence (A,E,I,M). All images were captured using an EVOS FL Cell Imaging System EVOS™ M5000 (40× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Figure 4. JC-1 dye showing the effect of IC90 of cerivastatin (B,F,J,N), pitavastatin (C,G,K,O) and rosuvastatin (D,H,L,P) in trophozoites of Acanthamoeba castellanii Neff (AD), A. polyphaga (EH), A. griffini (IL) and A. quina (MP) for 24 h of incubation. JC-1 dye remained in its monomeric form inside the treated cells, emitting green fluorescence, suggesting that the statins could induce depolarization of the mitochondrial potential. In healthy trophozoites, JC-1 dye accumulated in aggregates inside the mitochondria, emitting red fluorescence (A,E,I,M). All images were captured using an EVOS FL Cell Imaging System EVOS™ M5000 (40× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Antibiotics 11 00280 g004
Figure 5. Detection of reactive oxygen species (ROS) in trophozoites of Acanthamoeba castellanii Neff (AD), A. polyphaga (EH), A. griffini (IL) and A. quina (MP), treated with the IC90 of cerivastatin (B,F,J,N), pitavastatin (C,G,K,O) and rosuvastatin (D,H,L,P) for 24 h, and comparing with the negative control (A,E,I,M). CellROX™ Deep Red Reagent emitted bright red fluorescence in the presence of ROS. All images were captured using an EVOS FL Cell Imaging System EVOS™ M5000 (40× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Figure 5. Detection of reactive oxygen species (ROS) in trophozoites of Acanthamoeba castellanii Neff (AD), A. polyphaga (EH), A. griffini (IL) and A. quina (MP), treated with the IC90 of cerivastatin (B,F,J,N), pitavastatin (C,G,K,O) and rosuvastatin (D,H,L,P) for 24 h, and comparing with the negative control (A,E,I,M). CellROX™ Deep Red Reagent emitted bright red fluorescence in the presence of ROS. All images were captured using an EVOS FL Cell Imaging System EVOS™ M5000 (40× magnification). Images shown are representative of the cell populations observed in each experimental condition.
Antibiotics 11 00280 g005
Table 1. Amoebicidal activity of the three statins against both cysts and trophozoites of Acanthamoeba spp. IC50 (µM).
Table 1. Amoebicidal activity of the three statins against both cysts and trophozoites of Acanthamoeba spp. IC50 (µM).
A. castellanii NeffA. polyphagaA. griffiniA. quina
TrophozoiteCystTrophozoiteCystTrophozoiteCystTrophozoiteCyst
Cerivastatin0.114 ± 0.050 Aa0.704 ± 0.129 Aa0.939 ± 0.102 Ca20.037 ± 0.042 Da0.384 ± 0.064 Ba2.108 ± 0.046 Ba0.274 ± 0.046 ABa5.531 ± 0.941 Ca
Rosuvastatin5.583 ± 0.750 Ab18.168 ± 2.064 Ab16.463 ± 0.939 Cb>100 Cc8.582 ± 1.200 Bb23.738 ± 3.853 Ab5.659 ± 1.117 Ab81.620 ± 4.964 Bb
Pitavastatin0.389 ± 0.047 ABa3.040 ± 0.249 Aa1.907 ± 0.364 Ca48.774 ± 3.031 Bb0.859 ± 0.093 Ba5.306 ± 0.068 Aa0.229 ± 0.035 Aa5.921 ± 0.159 Aa
Means within strains with different lower-case letters (a–c) are significantly different (p < 0.05). Means within compounds with different Upper-case letters (A–D) are significantly different (p < 0.05).
Table 2. IC90 of three different statins against Acanthamoeba spp. (µM).
Table 2. IC90 of three different statins against Acanthamoeba spp. (µM).
A. castellanii NeffA. polyphagaA. griffiniA. quina
Cerivastatin0.305 ± 0.1662.010 ± 0.0101.850 ± 0.2800.901 ± 0.143
Rosuvastatin12.806 ± 2.08147.728 ± 5.36226.552 ± 5.58314.010 ± 2.025
Pitavastatin0.859 ± 0.1635.208 ± 1.1066.817 ± 4.7280.695 ± 0.075
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rodríguez-Expósito, R.L.; Sifaoui, I.; Reyes-Batlle, M.; Maciver, S.K.; Piñero, J.E.; Lorenzo-Morales, J. Statins Induce Actin Cytoskeleton Disassembly and an Apoptosis-Like Process in Acanthamoeba spp. Antibiotics 2022, 11, 280. https://doi.org/10.3390/antibiotics11020280

AMA Style

Rodríguez-Expósito RL, Sifaoui I, Reyes-Batlle M, Maciver SK, Piñero JE, Lorenzo-Morales J. Statins Induce Actin Cytoskeleton Disassembly and an Apoptosis-Like Process in Acanthamoeba spp. Antibiotics. 2022; 11(2):280. https://doi.org/10.3390/antibiotics11020280

Chicago/Turabian Style

Rodríguez-Expósito, Rubén L., Ines Sifaoui, María Reyes-Batlle, Sutherland K. Maciver, José E. Piñero, and Jacob Lorenzo-Morales. 2022. "Statins Induce Actin Cytoskeleton Disassembly and an Apoptosis-Like Process in Acanthamoeba spp." Antibiotics 11, no. 2: 280. https://doi.org/10.3390/antibiotics11020280

APA Style

Rodríguez-Expósito, R. L., Sifaoui, I., Reyes-Batlle, M., Maciver, S. K., Piñero, J. E., & Lorenzo-Morales, J. (2022). Statins Induce Actin Cytoskeleton Disassembly and an Apoptosis-Like Process in Acanthamoeba spp. Antibiotics, 11(2), 280. https://doi.org/10.3390/antibiotics11020280

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop